View Single Post
Old 03-24-2006, 09:45 AM   #14
saleboat
Senior Member
 
saleboat's Avatar
 
Join Date: Sep 2005
Location: NYC
Posts: 250
Hi,

I think the real question is whether or not bisphosphanates are going to become standard of care for early-stage bc patients for prevention of bone mets. As it stands, this type of therapy is only available off-label/protocal for prevention of mets for early-stagers. Has anyone heard anything different given the study that was posted?

Jen
saleboat is offline   Reply With Quote